SCHEMBL4681097

SCHEMBL4681097

CS(=O)(=O)c1ccccc1-c1ccc(N2CCCC(C(=O)NC(=O)c3ccccc3)C2=O)c(F)c1

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
F10 P00742 14/20 0.65
FPR2 P25090 6/20 0.63
FPR1 P21462 4/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4680928 0.89 F10 (0.65) F10FPR2
SCHEMBL4681099 0.86 F10 (0.85) F10FPR2FPR1
SCHEMBL18955218 0.81 FPR2 (0.77) F10FPR2FPR1
SCHEMBL20555885 0.81 FPR2 (0.77) F10FPR2FPR1
SCHEMBL4684779 0.81 F10 (0.85) F10FPR2FPR1
SCHEMBL4678706 0.80 F10 (0.82) F10FPR2FPR1
SCHEMBL4683366 0.79 F10 (0.69) F10FPR2FPR1
SCHEMBL4682683 0.79 F10 (0.69) F10FPR2FPR1
SCHEMBL4684708 0.79 F10 (1.00) F10FPR2FPR1
SCHEMBL4682787 0.79 FPR2 (0.80) F10FPR2FPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337251-B1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2008-08-20 EP claimed